[1]³ÂÊæÑÅ,ÕÅÕðÓî,Àî½ð·ï*.¸ÆÎÀµ°°×ÔÚÈÑÉﲡÀíÉúÀíÖеÄÑо¿½øÕ¹[J].Öйú¼Æ»®ÉúÓýºÍ¸¾²ú¿Æ,2020,(8):11-14.

µã»÷¸´ÖÆ

¸ÆÎÀµ°°×ÔÚÈÑÉﲡÀíÉúÀíÖеÄÑо¿½øÕ¹

·ÖÏíµ½£º

²Î¿¼ÎÄÏ×/References:

£Û1£ÝKostakis ID, Cholidou KG, Kallianidis K, et al. The role of calprotectin in obstetrics and gynecology £ÛJ£Ý. European Journal of Obstetrics & Gynecology and Reproductive Biology, 2010, 151(1): 3ª²9. £Û2£ÝZygiel EM, Nolan EM. Transition metal sequestration by the hostª²defense protein calprotectin £ÛJ£Ý. Annual Review of Biochemistry, 2018, 87(1): 621ª²643. £Û3£ÝNilsen T, Sunde K, Larsson A. A new turbidimetric immunoassay for serum calprotectin for fully automatized clinical analysers £ÛJ£Ý. Journal of Inflammation, 2015, 12(1): 45. £Û4£ÝPruenster M, Vogl T, Roth J, et al. S100A8/A9: from basic science to clinical application £ÛJ£Ý. Pharmacology & Therapeutics, 2016, 167: 120ª²131. £Û5£ÝSimm M, S¢‰derberg E, Larsson A, et al. Performance of plasma calprotectin as a biomarker of early sepsis: a pilot study £ÛJ£Ý. Biomarkers in Medicine, 2016, 10(8): 811ª²818. £Û6£ÝBart¨¢kov¨¢ E, ¦ktefan M, Str¨¢n¨ªkov¨¢ A, et al. Calprotectin and calgranulin C serum levels in bacterial sepsis £ÛJ£Ý. Diagnostic Microbiology and Infectious Disease, 2019, 93(3): 219ª²226. £Û7£ÝNilsen T, Haugen SH, Larsson A. Extraction, isolation, and concentration of calprotectin antigen (S100A8/S100A9) from granulocytes £ÛJ£Ý. Health Science Reports, 2018, 1(5): e 35. £Û8£ÝHeida A, Park KT, Van Rheenen PF. Clinical utility of fecal calprotectin monitoring in asymptomatic patients with inflammatory bowel disease: a systematic review and practical guide £ÛJ£Ý. Inflammatory Bowel Diseases, 2017, 23(6): 894ª²902. £Û9£ÝSattari M, Pazhang Y, Imani M. Calprotectin induces cell death in human prostate cancer cell (LNCaP) through survivin protein alteration £ÛJ£Ý. Cell Biology International, 2014, 38(11):1311ª²1320. £Û10£ÝBaker TM, Nakashige TG, Nolan EM, et al. Magnetic circular dichroism studies of Iron(ii) binding to human calprotectin £ÛJ£Ý. Chemical Science, 2017, 8(2): 1369ª²1377. £Û11£ÝNakashige TG, Zhang B, Krebs C, et al. Human calprotectin is an ironª²sequestering hostª²defense protein £ÛJ£Ý. Nature Chemical Biology, 2015, 11(10): 765. £Û12£ÝHeather L C, Anupam J, Yan Sun, et al. Zinc and Manganese chelation by neutrophil S100A8/A9 (calprotectin) limits extracellular aspergillus fumigatus hyphal growth and corneal infection £ÛJ£Ý. Journal of Immunology, 2016, 196(1): 336ª²344. £Û13£ÝLinerang Z R, Brittany L N, Wang Jiefei, et al. An acinetobacter baumannii, Zincª²Regulated peptidase maintains cell wall integrity during Immuneª²Mediated nutrient sequestration £ÛJ£Ý. Cell Reports, 2019, 26(8): 2009ª²2018.e 6. £Û14£ÝSteinbakk M, Andresen C N, Fagerhol M K, et al. Antimicrobial actions of Calcium binding leucocyte L1 protein, calprotectin £ÛJ£Ý. The Lancet, 1990, 336(8718): 763ª²765. £Û15£ÝViemann D, Strey A, Janning A, et al. Myeloidª²related proteins 8 and 14 induce a specific inflammatory response in human microvascular endothelial cells £ÛJ£Ý. Blood, 2005, 105(7): 2955ª²2962. £Û16£ÝHavelock J C, Patrick K, Ndaya M, et al. Human myometrial gene expression before and during parturition1 £ÛJ£Ý. Biology of Reproduction, 2005, 72(3): 707ª²719. £Û17£ÝPassey R J, Wikkiams E, Lichanska A M, et al. A null mutation in the inflammationª²associated S100 protein S100A8 causes early resorption of the mouse embryo £ÛJ£Ý. Journal of Immunology (Baltimore, Md. : 1950), 1999, 163(4): 2209ª²2216. £Û18£ÝCallejaª²agtus J, Jauniaux E, Pizzey A R, et al. Investigation of systemic inflammatory response in first trimester pregnancy failure £ÛJ£Ý. Human Reproduction, 2012, 27(2): 349ª²357. £Û19£ÝSato N, Isono K, Ishiwata I, et al. Tissue expression of the S100 protein familyª²related MRP8 gene in human chorionic villi by in situ hybridization techniques £ÛJ£Ý. Okajimas Folia Anatomica Japonica, 1999, 76(2/3): 123ª²129. £Û20£ÝRohini R N, Khanna A, Kiran S. Association of increased S100A8 serum protein with early pregnancy loss £ÛJ£Ý. American Journal of Reproductive Immunology, 2015, 73(2): 91ª²94. £Û21£ÝNair R R, Khanna A, Singh K. Role of inflammatory proteins S100A8 and S100A9 in pathophysiology of recurrent early pregnancy loss £ÛJ£Ý. Placenta, 2013, 34(9): 824ª²827. £Û22£ÝElizabeth A P, Thadhani R, Benzing T, et al. Preª²eclampsia: pathogenesis, novel diagnostics and therapies £ÛJ£Ý. Nature Reviews Nephrology, 2019, 15(5): 275ª²289. £Û23£ÝSa Ka ru manchi. Angiogenic factors in preeclampsia:from diagnosis to therapy £ÛJ£Ý. Hypertension, 2016, 67(6): 1072ª²1079. £Û24£ÝLu Huiqing, Rong Hu. The role of immunity in the pathogenesis and development of pre©\eclampsia £ÛJ£Ý. Scandinavian Journal of Immunology, 2019, 90(5): e 12756. £Û25£ÝChen Jiying, Zhao Lijian, Wang Dengchuan, et al. Contribution of regulatory T cells to immune tolerance and association of microRNA 210 and Foxp3 in preeclampsia£ÛJ£Ý. Molecular Medicine Reports, 2018, 19(2): 1150ª²1158. £Û26£ÝLamarca B, Cornelius D C, Ashlyn C H, et al. Identifying immune mechanisms mediating the hypertension during preeclampsia £ÛJ£Ý. American Journal of Physiologyª²Regulatory Integrative and Comparative Physiology,2016,311(1):R 1ª²R 9. £Û27£ÝKelsey R B, Newellª²rogers M K, Mitchell B M. Four pathways involving innate immunity in the pathogenesis of preeclampsia £ÛJ£Ý. Frontiers in Cardiovascular Medicine, 2015, 2(4):20. £Û28£ÝLaresgoitiª²servitje E. A leading role for the immune system in the pathophysiology of preeclampsia £ÛJ£Ý. Journal of Leukocyte Biology, 2013, 94(2): 247ª²257. £Û29£ÝVasilios P, Anastasla P, Eleni P, et al. An evaluation of calprotectin as serum marker of preeclampsia: a systematic review of observational studies £ÛJ£Ý. Inflammation Research, 2016, 65(2): 95ª²102. £Û30£Ý·ë³å£¬µÔ½¨¾ü£¬¸¶Óñ¾²£¬µÈ£®¸ÆÎÀµ°°×ºÍTNFª²¦ÁÔÚÈÑÉïÆÚ¸ßѪѹ¼²²¡Öеıí´ï¼°ÆäÒâÒå £ÛJ£Ý£®ÖйúÓÅÉúÓëÒÅ´«ÔÓÖ¾£¬2013£¬21£¨3£©£º25ª²27, ·â4£® £Û31£ÝLi Jinfeng, Huang Lifeng, Wang Shuzhen, et al. Increased serum levels of high mobility group protein B1 and calprotectin in preª²eclampsia £ÛJ£Ý. International Journal of Gynecology & Obstetrics, 2018, 142(1): 37ª²41. £Û32£ÝBraekke K, Holthe M R, Harsem N K, et al. Calprotectin, a marker of inflammation, is elevated in the maternal but not in the fetal circulation in preeclampsia £ÛJ£Ý. American Journal of Obstetrics and Gynecology, 2005, 193(1): 227ª²233. £Û33£ÝMuhammed ÿðþ ‰C I¡¤, Muhammed A A, Ahmet C D, et al. Aspartateª²aminotransferase to platelet ratio index score for predicting HELLP syndrome £ÛJ£Ý. The American Journal of Emergency Medicine, 2019(Article in press,doi:10.1016/j.ajem.2019.02.014,PMID:30777375) £Û34£ÝBuimer M, Wassenaer A V, Jokeh K. Postnatal administration of dexamethasone for weaning off the ventilator affects thyroid function £ÛJ£Ý. Neonatology, 2008, 94(3): 164ª²169. £Û35£ÝButmer M, Keijser R, Jebbink J M, et al. Seven placental transcripts characterize HELLPª²syndrome £ÛJ£Ý. Placenta, 2008, 29(5): 444ª²453. £Û36£ÝFaro J, Romero R, Schwenkel G, et al. Intraª²amniotic inflammation induces preterm birth by activating the NLRP3 inflammasome? £ÛJ£Ý. Biology of Reproduction, 2019, 100(5): 1290ª²1305. £Û37£ÝChungª²min S. Reply¡ªvaginal sampling of amniotic fluid in preterm premature rupture of membranes:a new technique for early detection of subclinical chorioamnionitis? £ÛJ£Ý. Pediatrics & Neonatology, 2015, 56(1): 72ª²73. £Û38£ÝR¨¹etschi U, Ros¨¦n A, Karlsson G, et al. Proteomic analysis using protein chips to detect biomarkers in cervical and amniotic fluid in women with Intraª²Amniotic inflammation£ÛJ£Ý. Journal of Proteome Research, 2005, 4(6): 2236ª²2242. £Û39£ÝMichael G G. Diagnosis of intraª²amniotic infection by proteomic profiling and identification of novel biomarkers £ÛJ£Ý. JAMA : the Journal of the American Medical Association, 2004, 292(4): 462. £Û40£ÝHassan MI, Kumar V, Singh TP, et al. Proteomic analysis of human amniotic fluid from Rhª²pregnancy £ÛJ£Ý. Prenatal Diagnosis, 2008, 28(2): 102ª²108. £Û41£ÝLiu Yinglin, Liu Yukun, Du Chuying, et al. Diagnostic value of amniotic fluid inflammatory biomarkers for subclinical chorioamnionitis £ÛJ£Ý. International Journal of Gynecology & Obstetrics, 2016, 134(2): 160ª²164.